We are international
Donate
publications TEXT SIZE   
meeting highlights    back

KOS 2007: The Treatment of Relapsed and Refractory Myeloma: Focus on Bortezomib and Bortezomib-based Combinations
Paul Richardson, MD
Medical Oncology
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA, USA
06.27.07

Be the first to comment

 related articles